Biogen Inc (BIIB)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$171.09
Buy
$171.37
$-4.51 (-2.57%)
Prices updated at 16 Dec 2025, 15:42 EST
| Prices minimum 15 mins delay
Prices in USD
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Most recent dividend payment
| - | |
| - | |
| - | |
| - | |
| - | |
| - |
Total dividend yield
Dividend history and forecast data table
| Year | Dividend per share | Dividend growth (%) |
|---|---|---|
| 2025 | - | - |
| 2024 | - | - |
| 2023 | - | - |
| 2022 | - | - |
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | - | - |
| 2016 | - | - |
Total dividend yield data table
Year | Dividend yield (%) | Buyback yield (%) |
|---|---|---|
| 2025 | - | - |
| 2024 | - | - |
| 2023 | - | - |
| 2022 | - | 1.88 |
| 2021 | - | 6.24 |
| 2020 | - | 22.44 |
| 2019 | - | 9.92 |
| 2018 | - | 5.06 |
| 2017 | - | 2.99 |
| 2016 | - | 3.81 |
Dividend per share
No data available
% of earnings paid to shareholders
No data available
Dividend per share data table
| Year | Dividend per share |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
% of earnings paid to shareholders data table
| Year | Payout ratio (%) |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
Latest Financial Report as of 15 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.
